Visudyne

Visudyne (verteporfin) is an intravenous medication used in photodynamic therapy for certain eye conditions. Administered by healthcare professionals, it targets abnormal blood vessels in the retina. This overview covers general uses and handling notes for informational purposes.

Visudyne is primarily used in photodynamic therapy to treat eye conditions involving abnormal blood vessel growth, such as age-related macular degeneration. It may also be used for other retinal disorders as determined by a healthcare provider. This therapy combines the drug with laser light to target specific areas. Always consult a medical professional for personalized treatment plans.

After administration, Visudyne circulates in the body and accumulates in abnormal blood vessels. When activated by laser light during therapy, it helps to close these vessels. Patients may experience temporary sensitivity to light following treatment. The effects are localized to the treated area and do not affect the entire body.

Visudyne should only be handled and administered by trained healthcare professionals in a clinical setting. Patients must avoid direct sunlight and bright indoor lights for several days after treatment to prevent skin reactions. Protective clothing and sunglasses are recommended during this period. Inform your provider about any allergies or medical conditions before receiving Visudyne.

Visudyne may interact with other medications that increase sensitivity to light, such as certain antibiotics or diuretics. Combining it with these drugs could heighten the risk of skin reactions. Always disclose all medications and supplements to your healthcare provider before starting Visudyne therapy. No specific drug interactions are widely reported, but caution is advised.